NFKB1 and diabetic kidney disease: In DKD, gut microbiota-derived OMVs activate TLR4 receptor, Caspase-11 pathway and NF-κB pathway by releasing LPS, and promote the accumulation of inflammatory factors in the renal tubulointerstitium.